Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950144-04-002485
Filing Date
2004-03-15
Accepted
2004-03-15 11:45:45
Documents
8
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 KOS PHARMACEUTICALS, INC. FORM 10-K g87743e10vk.htm 10-K 622463
3 SUBSIDIARIES OF THE COMPANY g87743exv21.htm EX-21 2020
4 CONSENT OF ERNST & YOUNG LLP g87743exv23w1.htm EX-23.1 1457
5 NOTICE REGARDING CONSENT OF ARTHUR ANDERSEN LLP g87743exv23w2.htm EX-23.2 3283
6 CERTIFICATION OF PRESIDENT & CEO g87743exv31w1.htm EX-31.1 6147
7 CERTIFICATION OF CHIEF FINANCIAL OFFICER g87743exv31w2.htm EX-31.2 6143
8 CERTIFICATION OF PRESIDENT & CEO SECTION 906 g87743exv32w1.htm EX-32.1 2009
9 CERTIFICATION OF CFO SECTION 906 g87743exv32w2.htm EX-32.2 2000
  Complete submission text file 0000950144-04-002485.txt   647906
Mailing Address
Business Address 1001 BRICKELL BAY DR STE 25 MIAMI FL 33131 3055773464
KOS PHARMACEUTICALS INC (Filer) CIK: 0001018952 (see all company filings)

EIN.: 650670898 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-22171 | Film No.: 04668331
SIC: 2834 Pharmaceutical Preparations